Optimal electrocardiographic leads for detecting acute myocardial ischemia.
B M Horácek, J W Warren, C J Penney...
https://pubmed.ncbi.nlm.nih.gov/11781943/Actively Recruiting
Led by Clinique Bizet · Updated on 2026-09-11
50
Participants Needed
2
Research Sites
12 weeks
Total Duration
The trial compares the time taken to record a complete Electrocardiogram ECG using a novel 4-electrode tablet device called DigitalCardio CardioSecur4 with a standard 12-lead ECG device in adults with cardiac conditions. It aims to determine differences in recording time, trace quality, and healthcare professional satisfaction between the two ECG methods. The study uses a randomized, crossover design with hospitalized and outpatient cardiology patients who are hemodynamically stable and able to consent. Participants are randomly assigned to one of two groups Group A undergoes the standard 10-electrode ECG first followed immediately by the 4-electrode DigitalCardio ECG, while Group B receives the DigitalCardio ECG first followed by the standard ECG. Both ECG recordings are performed by the same operator within a short interval to ensure consistency. Anonymized ECG traces are assessed independently for quality, diagnostic parameters, and any missing or erroneous leads. During the trial, researchers measure the total time from electrode placement to complete ECG trace capture for each device. Healthcare professionals complete a questionnaire to evaluate their satisfaction with the DigitalCardio system. The study includes initial screening for eligibility and informed consent. Outcome measures include procedure time comparison, trace quality, diagnostic concordance, user satisfaction, and technical incident rates. The trial is conducted in a single day per participant with no long-term follow-up.
CONDITIONS
4-electrode ECG (DigitalCardio®) vs Standard 10-electrode ECG: Evaluating Ease of Use and Recording Quality
B
Bouchra BENKESSOU Chef de projet Recherche Clinique
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Clinique Bizet
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Up to 2 weeks
Participants are screened for eligibility and provide informed consent to join the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo both ECG recording methods sequentially: the standard 10-electrode ECG and the 4-electrode DigitalCardio tablet ECG. The same operator performs both to ensure consistency.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
B M Horácek, J W Warren, C J Penney...
https://pubmed.ncbi.nlm.nih.gov/11781943/P Denes
https://pubmed.ncbi.nlm.nih.gov/1382387/Sebastian Spaich, Hanna Kern, Thomas A Zelniker...
https://pubmed.ncbi.nlm.nih.gov/33195450/Peter J Zimetbaum, Mark E Josephson
https://pubmed.ncbi.nlm.nih.gov/12621138/Borja Ibanez, Stefan James, Stefan Agewall...
https://pubmed.ncbi.nlm.nih.gov/28886621/Galen S Wagner, Peter Macfarlane, Hein Wellens...
https://pubmed.ncbi.nlm.nih.gov/19281933/Harvey Johnson, Nuno Duarte, Diane Ryding...
https://pubmed.ncbi.nlm.nih.gov/34388845/Juan Pablo Martínez, Pablo Laguna, Salvador Olmos...
https://pubmed.ncbi.nlm.nih.gov/17027840/Stefan P Nelwan, Jan A Kors, Suzanne W Crater...
https://pubmed.ncbi.nlm.nih.gov/18433614/B J Drew, B Ide
https://pubmed.ncbi.nlm.nih.gov/8657711/Clinique Bizet
Lead Sponsor